Chongqing Zhifei Biological Products Co Ltd
SZSE:300122

Watchlist Manager
Chongqing Zhifei Biological Products Co Ltd Logo
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Watchlist
Price: 30.88 CNY -5.07% Market Closed
Market Cap: 74.1B CNY
Have any thoughts about
Chongqing Zhifei Biological Products Co Ltd?
Write Note

Relative Value

The Relative Value of one Chongqing Zhifei Biological Products Co Ltd stock under the Base Case scenario is 59.6 CNY. Compared to the current market price of 30.88 CNY, Chongqing Zhifei Biological Products Co Ltd is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
59.6 CNY
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
86
Median 3Y
2.8
Median 5Y
3.8
Industry
8.1
Forward
1.6
vs History
76
vs Industry
10
Median 3Y
13.7
Median 5Y
18
Industry
23
Forward
10.7
vs History
92
vs Industry
11
Median 3Y
18.8
Median 5Y
36.7
Industry
23.4
vs History
71
vs Industry
3
Median 3Y
33.1
Median 5Y
46.7
Industry
27.3
vs History
92
vs Industry
42
Median 3Y
4.8
Median 5Y
6.2
Industry
2.6
vs History
88
vs Industry
76
Median 3Y
2.8
Median 5Y
3.9
Industry
8.1
Forward
1.5
vs History
85
vs Industry
56
Median 3Y
8.3
Median 5Y
10.5
Industry
9.6
vs History
76
vs Industry
11
Median 3Y
11.4
Median 5Y
15.3
Industry
4.3
Forward
9
vs History
76
vs Industry
9
Median 3Y
11.4
Median 5Y
15.3
Industry
3.8
Forward
9.1
vs History
92
vs Industry
11
Median 3Y
18.8
Median 5Y
37.8
Industry
6
vs History
80
vs Industry
8
Median 3Y
18.3
Median 5Y
28
Industry
3.8
vs History
92
vs Industry
47
Median 3Y
4.5
Median 5Y
6.2
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Chongqing Zhifei Biological Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
73.9B CNY 1.6 12.2 10.3 10.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average P/E: 178.5
12.2
7%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average EV/EBITDA: 16.8
10.3
7%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Average EV/EBIT: 21.3
10.3
0%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top